Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family.
about
Interaction of soluble CD163 with activated T lymphocytes involves its association with non-muscle myosin heavy chain type AElevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug developmentDifferential neuropathic pain sensitivity and expression of spinal mediators in Lewis and Fischer 344 ratsHigh serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C.Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and mu opioid receptor protein expression while enhancing perivascular microglial ED2.Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes.Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseModulation of CD163 expression by metalloprotease ADAM17 regulates porcine reproductive and respiratory syndrome virus entryHistiocytic sarcoma: a study of five cases including the histiocyte marker CD163.Transmodulation of cell surface regulatory molecules via ectodomain shedding.Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-aSoluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disordersUpdate on the immunological pathway of negative regulation in acute insults and sepsisSoluble CD163 from activated macrophages predicts mortality in acute liver failure.Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease.Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injurySpinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury.A general map of iron metabolism and tissue-specific subnetworks.CD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage.Neuroimmune interactions and pain: focus on glial-modulating targetsMonocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans.Functional expression of the CD163 scavenger receptor on acute myeloid leukemia cells of monocytic lineage.Serum levels of the soluble haemoglobin scavenger receptor CD163 in MPO-ANCA-associated renal vasculitis.Levels of soluble CD163 and severity of malaria in children in Ghana.Diagnostic value of serum concentrations of high-mobility group-box protein 1 and soluble hemoglobin scavenger receptor in brucellosis.Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries.Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.Diagnostic value of soluble CD163 serum levels in patients suspected of meningitis: comparison with CRP and procalcitonin.A malaria scavenger receptor-like protein essential for parasite development.Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163.Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients.
P2860
Q24306764-5ACDB89A-778D-432D-B32E-DD4E531F9C1BQ24681059-7ECDD1ED-E406-473D-B282-9C5E9D7E17F0Q28251468-C403A0B7-C850-4FA4-BF82-ECAC18A11DF6Q30440497-BEC1359E-E27F-423F-8FF3-2C3DDA5D67DEQ33765551-2BB3E101-2439-449F-8603-3769E0483B77Q33916381-D3C12669-AAA2-41BD-8350-9ACC02F289AAQ33942120-48AE333F-80F7-4213-8889-96471AFE31E2Q34065061-7514CC66-95E5-4843-A2FC-507E5729CFC1Q34115929-456C5DA4-BEA0-4AB1-939E-10EFC43A3BCAQ34115973-94C6AE1A-8D39-42DC-930F-7EF132360B70Q34147333-A918617E-5C42-4522-AA2E-CCFCD58C2E0CQ34218552-A38D6999-6E64-401E-82FD-10A655E8A6DBQ34262328-44D23B4D-767C-4DE5-AEC2-E9AF6C596C6AQ34391799-C3FB5DEA-B951-44CB-A0CC-C2FF21A0B9BFQ34584816-6C708BA2-6254-49AF-9CAF-2A76BD9C85B5Q34718135-7437F0EC-9D9E-4A20-B3DF-073712F492D8Q35016650-3E799425-7D9C-417E-869F-A5F671F60C3AQ35154529-5F1C9CA0-3645-4F25-A266-DAA2CD12DCE4Q36079845-E37342DA-BDEB-44F6-9B5E-16DDB170E106Q36333669-D4CFA31D-80A7-4C50-9EF5-87A5E2DB55AFQ36521192-1849E218-64D5-49F7-AB06-92101709C432Q36862945-DE17C220-BA4F-467F-9253-5F83A52263C2Q36943867-EAF8D1A0-5E1E-4C26-BD72-78E65828EB7FQ37031812-DD13802C-942B-4EB3-BB6E-35984368FEFFQ37108580-6AB13B3D-BC84-4291-B8CA-AFB64FC5ECE5Q37187218-D545EEC6-4ECF-4B12-BCA9-381583A1D5B2Q37196512-0A95A29C-067D-4799-9CB3-58134588CB58Q37207178-1DD4658C-2AB4-45DE-94A1-80A78F4633D3Q37968178-B2AACD8C-70F8-48A6-AB8F-38BE9A82AFD7Q40337699-20A5BEF6-1038-4552-8FFE-2AA212D7C25EQ40707608-68E70991-CF15-4AFA-81F8-5B13228FA05BQ41833572-3B3148A0-136A-4153-B990-07C68922B95DQ42280585-363182BA-B473-4A3C-8092-C6B7C3D8B189Q42750527-89CEDD82-5529-44A1-BEB1-730CF25BF701Q42921094-AF3C9096-1E20-49C1-BC2C-FA8725510EBCQ43935926-E1CE103E-4D62-40D7-9861-4D7AB71B81EAQ44149219-960B0164-483D-43E8-B058-75410AC799BBQ44318263-04EE13DD-E126-43A7-AB47-A628D9866F8CQ44838325-F9C1EC43-AE5A-46C8-880C-82BB99F8A324Q46898742-D822A70D-881F-4AFE-875B-60680C1E15C5
P2860
Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Shedding of CD163, a novel reg ...... receptor cysteine-rich family.
@ast
Shedding of CD163, a novel reg ...... receptor cysteine-rich family.
@en
type
label
Shedding of CD163, a novel reg ...... receptor cysteine-rich family.
@ast
Shedding of CD163, a novel reg ...... receptor cysteine-rich family.
@en
prefLabel
Shedding of CD163, a novel reg ...... receptor cysteine-rich family.
@ast
Shedding of CD163, a novel reg ...... receptor cysteine-rich family.
@en
P2093
P356
P1476
Shedding of CD163, a novel reg ...... receptor cysteine-rich family.
@en
P2093
P304
P356
10.1006/BBRC.1999.0294
P407
P577
1999-03-01T00:00:00Z